Evidence map›Paper›PMID 34681788›Full record

ReviewInternational journal of molecular sciences2021

Hypoxia Tolerant Species: The Wisdom of Nature Translated into Targets for Stroke Therapy.

Carmen Del Río, Joan Montaner

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Neural Processing without OPhysiology (Bethesda, Md.) · 2024
    Review
  5. Review
  6. Article
  7. Cellular and Molecular Targets in Acute Ischemic Stroke.International journal of molecular sciences · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Carmen Del RíoInstitute of Biomedicine of Seville (IBiS), Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0003-2332-2216
Joan MontanerInstitute of Biomedicine of Seville (IBiS), Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla, 41013 Seville, Spain.
Hospital Universitario Virgen Macarena · ESInstituto de Biomedicina de Sevilla · ES

Funding

Ministerio de ciencia, innovación y universidades FJC2018-036897-IRegional Government of Andalusia PE-0527-2019
6 · The paper itself

Abstract

Human neurons rapidly die after ischemia and current therapies for stroke management are limited to restoration of blood flow to prevent further brain damage. Thrombolytics and mechanical thrombectomy are the available reperfusion treatments, but most of the patients remain untreated. Neuroprotective therapies focused on treating the pathogenic cascade of the disease have widely failed. However, many animal species demonstrate that neurons can survive the lack of oxygen for extended periods of time. Here, we reviewed the physiological and molecular pathways inherent to tolerant species that have been described to contribute to hypoxia tolerance. Among them, Foxo3 and Eif5A were reported to mediate anoxic survival in

Indexed as

AnimalsBrain InjuriesCaenorhabditis elegansDrosophilaHumansHypoxiaModels, BiologicalMolecular Targeted TherapyNeuroprotectionNeuroprotective AgentsSpecies SpecificityStrokeNeuroprotective Agentshypoxia toleranceneuroprotectionstrokestroke therapy

Identifiers

PMID34681788
PMCPMC8537001
OpenAlexW3205261131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.